IDiyas

For the Inventor, By the Inventor

Ramat Aviv, Israel

Simona Mendelovitz

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 241(Granted Patents)


Location History:

  • Ramat Aviv, IL (US) (2012)
  • Ramat Aviv, IL (2010 - 2023)

Company Filing History:

goldMedal9 out of 13 
 
Savient Pharmaceuticals, Inc.
 patents
silverMedal5 out of 9 
 
Horizon Pharma Rheumatology LLC
 patents
bronzeMedal2 out of 8 
 
Horizon Therapeutics Usa, Inc.
 patents
4. 1 out of 2 
 
Crealta Pharmaceuticals LLC
 patents

Years Active: 2010-2023

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 11781119 - Variant forms of urate oxidase and use thereof (2023-10-10),
2. 11345899 - Variant forms of urate oxidase and use thereof (2022-05-31),
3. 10731139 - Variant forms of urate oxidase and use thereof (2020-08-04),
4. 10160958 - Variant forms of urate oxidase and use thereof (2018-12-25),
5. 9926538 - Variant forms of urate oxidase and use thereof (2018-03-27),
6. 9926537 - Variant forms of urate oxidase and use thereof (2018-03-27),
7. 9670467 - Variant forms of urate oxidase and use thereof (2017-06-06),
8. 9017980 - Variant forms of urate oxidase and use thereof (2015-04-28),
9. 8541205 - Variant forms of urate oxidase and use thereof (2013-09-24),
10. 8465735 - Variant form of urate oxidase and use thereof (2013-06-18),
11. 8293228 - Variant form of urate oxidase and use thereof (2012-10-23),
12. 8188224 - Variant forms of urate oxidase and use thereof (2012-05-29),
13. 8178334 - Variant form of urate oxidase and use thereof (2012-05-15),
14. 8148123 - Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase (2012-04-03),
15. 8034594 - Variant form of urate oxidase and use thereof (2011-10-11),

Title: The Innovative Journey of Simona Mendelovitz

Introduction: Simona Mendelovitz, based in Ramat Aviv, Israel, is a distinguished inventor with an impressive portfolio of 17 patents. Her groundbreaking work primarily focuses on genetically modified proteins that serve critical functions in medical applications. Mendelovitz's innovative contributions have significantly advanced our understanding and treatment of conditions related to uric acid levels.

Latest Patents: Among her latest patents, Mendelovitz has developed variant forms of urate oxidase, which are genetically modified proteins characterized by uricolytic activity. These innovations include proteins comprising truncated urate oxidases and methods for producing them, notably incorporating PEGylated proteins. This technology is aimed at improving the efficacy and delivery of treatments for conditions influenced by uric acid.

Career Highlights: Over the years, Simona Mendelovitz has made substantial contributions to the pharmaceutical landscape, particularly while working for notable companies like Savient Pharmaceuticals and Horizon Pharma Rheumatology. Her dedication to research and innovation has allowed her to emerge as a key player in her field, driving advancements in therapeutic approaches.

Collaborations: Throughout her career, Mendelovitz has collaborated with esteemed colleagues, including Jacob R. Hartman and Claudia D. Rehrig. These partnerships have not only enriched her work but have also fostered a spirit of collaboration that is essential for the progress of scientific research and innovation.

Conclusion: Simona Mendelovitz exemplifies the role of a visionary inventor in the realm of biotechnology. With her 17 patents and a focus on developing advanced urate oxidase variants, she continues to pave the way for innovative solutions that address important medical challenges. As the field of biotechnology grows, her contributions will undoubtedly leave a lasting impact on future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…